EUR 9.35
(3.43%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 24.8 Million | -509.72 Million | 576.23 Million | 55.55 Million | 53.05 Million | 42 Million |
Net Income | 106.2 Million | 63.97 Million | 84.62 Million | 54.79 Million | 74.75 Million | 67.58 Million |
Depreciation & Amortization | 20.5 Million | 18.87 Million | 16.62 Million | 12.6 Million | 12.7 Million | 13.38 Million |
Deferred income taxes | -2.2 Million | - | -21.36 Million | -4.86 Million | -13.9 Million | -13.34 Million |
Stock-based compensation | 1.89 Million | 1.59 Million | 804 Thousand | 90 Thousand | 712 Thousand | -897 Thousand |
Change in working capital | -95.9 Million | -615.13 Million | 490.22 Million | 625 Thousand | -24.02 Million | -31.43 Million |
Other non-cash items | -5.7 Million | 20.97 Million | 5.32 Million | -7.69 Million | 2.8 Million | 6.7 Million |
Investing Cash Flow | -43.7 Million | -14.8 Million | -126.41 Million | -5.6 Million | 4.76 Million | 10.55 Million |
Investments in PPE | -22 Million | -12.2 Million | -9.65 Million | -10.95 Million | -7.76 Million | -6.32 Million |
Acquisitions | -500 Thousand | -2.67 Million | -113.98 Million | 6.85 Million | 9.57 Million | 788 Thousand |
Investment purchases | -22.1 Million | -98.99 Million | -4.12 Million | -107.73 Million | -70.12 Million | -5.03 Million |
Sales/Maturities of investments | 22.1 Million | 98.99 Million | 127.74 Million | 107.73 Million | 10.81 Million | 523.85 Million |
Other Investing Activities | -21.2 Million | 79 Thousand | -126.39 Million | -1.49 Million | 62.26 Million | 16.09 Million |
Financing Cash Flow | -31.9 Million | -65.94 Million | -1.02 Million | -59.42 Million | -36.12 Million | -310.44 Million |
Debt repayment | -423.3 Million | -24.98 Million | -63.75 Million | -57.29 Million | -61.78 Million | -27.38 Million |
Dividends payments | -31.08 Million | -40.3 Million | -67.67 Million | - | -42.07 Million | -37.83 Million |
Common Stock Repurchased | -423.3 Million | - | 56 Million | - | - | - |
Common Stock Issuance | 1.5 Million | 1.67 Million | 14.94 Million | 917 Thousand | 745 Thousand | 1.19 Million |
Other Financing Activities | 844.3 Million | -2.32 Million | 59.46 Million | -3.04 Million | 66.98 Million | -245.22 Million |
Accounts receivables | 388.9 Million | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -95.9 Million | -615.13 Million | 490.22 Million | 625 Thousand | -24.02 Million | -116.69 Million |
Cash at beginning of period | 144.4 Million | 734.91 Million | 276.6 Million | 286.07 Million | 264.38 Million | 320.11 Million |
Cash at end of period | 93.7 Million | 144.44 Million | 734.91 Million | 276.6 Million | 286.07 Million | 306.92 Million |
Capital Expenditure | -22 Million | -12.2 Million | -9.65 Million | -10.95 Million | -7.76 Million | -6.32 Million |
Effect of forex changes on cash | 100 Thousand | -1000.00 | 9.51 Million | - | 1000.00 | -1000.00 |
Net cash flow / Change in cash | -50.7 Million | -590.46 Million | 458.3 Million | -9.46 Million | 21.69 Million | -13.19 Million |
Free Cash Flow | 2.8 Million | -521.92 Million | 566.57 Million | 44.6 Million | 45.29 Million | 35.67 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 24.1 Million | 27.2 Million | 106.2 Million | 25.2 Million | 32 Million | 26.8 Million |
Depreciation & Amortization | 6.1 Million | 6 Million | 20.5 Million | 6 Million | 5 Million | 4.7 Million |
Deferred income taxes | - | - | -2.2 Million | -300 Thousand | 9.6 Million | -2.3 Million |
Stock-based compensation | 500 Thousand | -2.9 Million | 1.89 Million | 799 Thousand | 1.1 Million | 1.3 Million |
Change in working capital | -5.9 Million | -73.4 Million | -95.9 Million | -21.1 Million | 11 Million | -8.2 Million |
Other non-cash items | 9 Million | 39.3 Million | -5.7 Million | -33.3 Million | -21.2 Million | 19.4 Million |
Investing Cash Flow | -8.7 Million | -5.9 Million | -43.7 Million | -21.5 Million | -13 Million | -5.4 Million |
Investments in PPE | -8.7 Million | -5.9 Million | -22 Million | -6.4 Million | -6 Million | -5.4 Million |
Acquisitions | - | - | -500 Thousand | -500 Thousand | -2.6 Million | - |
Investment purchases | - | - | -22.1 Million | -15.1 Million | 3 Million | -10 Million |
Sales/Maturities of investments | - | - | 22.1 Million | 15.1 Million | -400 Thousand | 400 Thousand |
Other Investing Activities | - | 200 Thousand | -21.2 Million | -14.6 Million | -7 Million | 9.6 Million |
Financing Cash Flow | -50.5 Million | 33.1 Million | -31.9 Million | -62.2 Million | 2.3 Million | -33.4 Million |
Debt repayment | - | -31.3 Million | -423.3 Million | - | -2.3 Million | -2.3 Million |
Dividends payments | -50.9 Million | - | -31.08 Million | -13 Thousand | - | -31.1 Million |
Common Stock Repurchased | - | - | -423.3 Million | - | - | - |
Common Stock Issuance | 400 Thousand | 1.8 Million | 1.5 Million | 39 Thousand | - | - |
Other Financing Activities | 400 Thousand | 1.8 Million | 844.3 Million | -31.13 Million | 4.6 Million | -2.3 Million |
Accounts receivables | -307.3 Million | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -5.9 Million | -73.4 Million | -95.9 Million | -21.1 Million | 11 Million | -8.2 Million |
Cash at beginning of period | 108 Million | 93.7 Million | 144.4 Million | 137.8 Million | 113.4 Million | 110.4 Million |
Cash at end of period | 69.9 Million | 108 Million | 93.7 Million | 93.7 Million | 137.8 Million | 113.4 Million |
Capital Expenditure | -8.7 Million | -5.9 Million | -22 Million | -6.4 Million | -6 Million | -5.4 Million |
Effect of forex changes on cash | - | - | 100 Thousand | 62.3 Million | -2.4 Million | 100 Thousand |
Net cash flow / Change in cash | -38.1 Million | 14.3 Million | -50.7 Million | -44.1 Million | 24.4 Million | 3 Million |
Free Cash Flow | 12.4 Million | -18.8 Million | 2.8 Million | -29.1 Million | 31.5 Million | 36.3 Million |
KNKT
ALSSF
LPLI
GOCO
CMPR
DCOMP